Acticor Biotech: Disclosure of The Total Number of Voting Rights and Shares as of March 31, 2023
Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies